TRPM4 has been reported to form a channel complex with sulfonylurea receptor-1 (SUR1), an auxiliary subunit of KATP channel [15], and SUR1 blocker sulfonylureas have been used to treat brain diseases such as stroke [20]. This evidence concerns the gene TRPM4 and stroke disorder.